Diabetes in the News

San Diego Padres left-hander David Wells has Type 2 diabetes
Wells’s condition was diagnosed two weeks ago, the San Diego Union-Tribune reported in yesterday’s editions.

Asked if he feels less energy at times, Wells said, “It depends.” He declined further comment.

Manager Bud Black said Wells needs to meet with doctors.

“From what I’ve been told, it’ll be manageable,” Black said.

The 43-year-old signed a one-year contract in January to return to his hometown Padres as the No. 5 starter. The 6-foot-3, 248-pound Wells has often battled his weight, and was scratched from a start late last season because of gout in his right foot. Source

Dietary patterns linked to type 2 diabetes risk
NEW YORK (Reuters Health) - Avoiding meats and fatty foods and eating lots of salads and cooked vegetables appears to reduce the risk of developing type 2 diabetes, according to study findings published in the American Journal of Epidemiology.

Dr. Allison Hodge, of the University of Melbourne, Australia, and colleagues examined the association between dietary patterns and type 2 diabetes in a 4-year study of 36,787 adults in the Melbourne Collaborative Cohort who provided dietary information. During follow-up, 365 new cases of type 2 diabetes were diagnosed.

The researchers defined four eating patterns, based on the predominance of 123 foods and beverages in the diet, which included: olive oil, salad, vegetables, legumes and avoidance of sweet bakery items, margarine and tea (Mediterranean); a variety of salads and vegetables (Salad and Vegetable); meats and fatty fried foods (Meat); and many different fruits (Fruit). Source

New Disposable Insulin Pens
Sanofi-aventis announced today that a new disposable insulin pen, SoloSTAR® for use with the 24-hour insulin LANTUS® or/and the rapid-acting insulin APIDRA® will be available in Europe starting April 2007. LANTUS®SoloSTAR® and APIDRA®SoloSTAR®, have previously received European Commission approval.

Sanofi-aventis, the developer, manufacturer and marketer of LANTUS®SoloSTAR® and APIDRA®SoloSTAR®, is currently building significant manufacturing capability to support worldwide launches. The first launch of LANTUS®SoloSTAR® is planned in Germany in April 2007.

SoloSTAR® is a new, easy-to-use disposable pen for administration of LANTUS® and APIDRA®. SoloSTAR® reduces the injection force by 30% or more in comparison to other leading disposable pens. This is beneficial for all people with diabetes and in particular for those with lower grip strength and the estimated up to 58% of individuals with limited joint mobility of the hand. SoloSTAR ® has the highest dose range of any disposable insulin pen with doses up to 80 units adjustable in 1 unit steps. To help with correct insulin identification and differentiation SoloSTAR® is also the only disposable insulin pen with a completely different pen colour for each different insulin.  Source

Tour de Cure
Amy from Diabetes Mine is cycling in the the American Diabetes Associations “Tour de Cure” fund raising event. If you would like to sponser Amy please go to her tour page.

Tour de Cure is a series of cycling events held in more than 80 cities nationwide to benefit the American Diabetes Association. The Tour is a ride, not a race, with routes designed for everyone from the occasional rider to the experienced cyclist. Whether you ride 10 miles or 100 miles, you’ll travel a route supported from start to finish with rest stops, food to fuel your journey and fans to cheer you on! Find your Tour de Cure!

—
Resources:
dLife; About Diabetes.com; American Diabetes Association

Technorati Tags:
Diabetes; Health News